Other languages Exicure, Inc.

Equities

Delayed Nasdaq Other stock markets 20:05:12 29/04/2024 BST			5-day change	1st Jan Change
0.5197 ^USD	+3.92%		-3.71%	-10.44%

03-22	North American Morning Briefing : Stocks Struggle After New Records	DJ
02-29	An unknown buyer agreed to acquire 39.3% stake in Exicure, Inc. from DGP Co.,Ltd. for KRW 6 billion.	CI

Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis	02-05
Wall Street Set to Open Lower Friday; Employment Growth Tops Forecasts	12-08
Investors Look Ahead to Economic Indicators as US Futures Trend Lower in Friday's Premarket	12-08
Top Premarket Gainers	12-08
Northwestern University Notifies Exicure, Inc. that it Was Terminating the 2014 License	06/10/23
Exicure, Inc. Appoints Minhee Eom to the Board	27/09/23
Exicure Appoints New CEO, CFO	23/08/23
Exicure, Inc. Announces Executive Changes	23/08/23
Exicure, Inc. Announces Executive Changes	23/08/23
Exicure Inc Provides Information to Shareholders	23/08/23
Exicure, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/08/23
CBI Co Provides Information to Shareholders of Exicure Inc	08/08/23
Exicure, Inc. Announces Resignation of Cheolho Jo from the Board and the Audit Committee	04/08/23
Exicure, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	14/07/23
Exicure, Inc. Appoints Jung Sang Kim as Chief Executive Officer	29/05/23
Exicure, Inc. Appoints Jung Sang Kim as Class II Director	29/05/23
Exicure Says Board Fully Backs CEO in Exploration of Strategic Alternatives	26/05/23
CBI USA Inc Sends a Letter to Exicure Inc	17/05/23
Exicure, Inc. Announces Board Changes	28/04/23
Exicure, Inc. Announces CEO Changes	28/04/23

No results for this search